For an administration that promises to pull back regulations, CVS Health's (CVS) plan to buy Aetna (AET) for some $69 billion will be a big test for the government, according to TD Ameritrade's chief market analyst JJ Kinahan.
Kinahan expects this deal to benefit consumers.
More of What's Trending on TheStreet:
- Trump Tax Plan Makes This Sector of the Stock Market Potentially Explosive
- Seven Great Holiday Gift Ideas from a Financial Advisor -- and Mom
- Anyone Who Resists the Rise of Legal Cannabis Is Among Dumbest on Wall Street
- Investing Like Warren Buffett Comes With a Big Challenge That Can't Be Overcome